Artificial intelligence in pharmacovigilance: Do we need explainability?
Manfred Hauben
Abstract
Manfred Hauben is an employee and stockholders of Pfizer, Incorporated. Manfred Hauben have no other conflicts of interest that are relevant to the content of this manuscript. Appendix S1 Supporting information Appendix S2 Supporting information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
PharmacovigilanceMedicineShareholderContent (measure theory)PharmacologyManagementDrugMathematical analysisCorporate governanceMathematicsEconomicsPharmacovigilance and Adverse Drug ReactionsAcademic integrity and plagiarismBiosimilars and Bioanalytical Methods